US Patent Issued to ONO PHARMACEUTICAL on April 8 for "Compound having KDM5 inhibitory activity and pharmaceutical use thereof" (American, Japanese Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,817, issued on April 8, was assigned to ONO PHARMACEUTICAL Co. LTD. (Osaka, Japan).

"Compound having KDM5 inhibitory activity and pharmaceutical use thereof" was invented by Akito Kakuuchi (Osaka, Japan), Shuhei Umemura (Osaka, Japan), Masaki Asada (Osaka, Japan), Anatoly Ruvinsky (Lexington, Mass.), Yan Zhang (New York), Hidenori Takahashi (Lagrangeville, N.Y.), Goran Krilov (Long Island City, N.Y.), Daigo Inoyama (Ridgewood, N.J.), Kyle Konze (Brooklyn, N.Y.) and Mats Svensson (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of following formula (I):in which all symbols have the same meanings as the definitions desc...